BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 16474432)

  • 21. An ex vivo human model system to evaluate specificity of replicating and non-replicating gene therapy agents.
    Rots MG; Elferink MG; Gommans WM; Oosterhuis D; Schalk JA; Curiel DT; Olinga P; Haisma HJ; Groothuis GM
    J Gene Med; 2006 Jan; 8(1):35-41. PubMed ID: 16044485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biological activities of a recombinant adenovirus p53 (SCH 58500) administered by hepatic arterial infusion in a Phase 1 colorectal cancer trial.
    Atencio IA; Grace M; Bordens R; Fritz M; Horowitz JA; Hutchins B; Indelicato S; Jacobs S; Kolz K; Maneval D; Musco ML; Shinoda J; Venook A; Wen S; Warren R
    Cancer Gene Ther; 2006 Feb; 13(2):169-81. PubMed ID: 16082381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effective gene therapy for medullary thyroid carcinoma using recombinant adenovirus inducing tumor-specific expression of interleukin-12.
    Yamazaki M; Zhang R; Straus FH; Messina M; Robinson BG; Hashizume K; DeGroot LJ
    Gene Ther; 2002 Jan; 9(1):64-74. PubMed ID: 11850724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment.
    Qiao J; Moreno J; Sanchez-Perez L; Kottke T; Thompson J; Caruso M; Diaz RM; Vile R
    Gene Ther; 2006 Oct; 13(20):1457-70. PubMed ID: 16724095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Helper-dependent adenovirus vectors elicit intact innate but attenuated adaptive host immune responses in vivo.
    Muruve DA; Cotter MJ; Zaiss AK; White LR; Liu Q; Chan T; Clark SA; Ross PJ; Meulenbroek RA; Maelandsmo GM; Parks RJ
    J Virol; 2004 Jun; 78(11):5966-72. PubMed ID: 15140994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Development of gene-viral vector and its anti-tumor effect, a primary study].
    Qian Q; Che X; Cen X; Cui Z; Xue H; Zhu B; Xu J; Billy ; Wu M
    Zhonghua Yi Xue Za Zhi; 2002 Apr; 82(8):557-60. PubMed ID: 12133505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy.
    Kim JH; Lee YS; Kim H; Huang JH; Yoon AR; Yun CO
    J Natl Cancer Inst; 2006 Oct; 98(20):1482-93. PubMed ID: 17047197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulated hsp70B' promoter: stringent heat-inducible activity in replication-deficient, but not replication-competent adenoviruses.
    Rohmer S; Mainka A; Knippertz I; Hesse A; Nettelbeck DM
    J Gene Med; 2008 Apr; 10(4):340-54. PubMed ID: 18265421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene therapy of cancer: induction of anti-tumor immunity.
    Qian C; Prieto J
    Cell Mol Immunol; 2004 Apr; 1(2):105-11. PubMed ID: 16212896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparative study on the immunotherapeutic efficacy of recombinant Semliki Forest virus and adenovirus vector systems in a murine model for cervical cancer.
    Riezebos-Brilman A; Walczak M; Regts J; Rots MG; Kamps G; Dontje B; Haisma HY; Wilschut J; Daemen T
    Gene Ther; 2007 Dec; 14(24):1695-704. PubMed ID: 17928874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concomitant use of Ad5/35 chimeric oncolytic adenovirus with TRAIL gene and taxol produces synergistic cytotoxicity in gastric cancer cells.
    Chen L; Chen D; Gong M; Na M; Li L; Wu H; Jiang L; Qian Y; Fang G; Xue X
    Cancer Lett; 2009 Nov; 284(2):141-8. PubMed ID: 19447545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of experimental osteoarthritis by adenovirus-mediated double gene transfer.
    Wang HJ; Yu CL; Kishi H; Motoki K; Mao ZB; Muraguchi A
    Chin Med J (Engl); 2006 Aug; 119(16):1365-73. PubMed ID: 16934183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Melanoma differentiation-associated gene-7 (mda-7)/interleukin (IL)-24 induces anticancer immunity in a syngeneic murine model.
    Miyahara R; Banerjee S; Kawano K; Efferson C; Tsuda N; Miyahara Y; Ioannides CG; Chada S; Ramesh R
    Cancer Gene Ther; 2006 Aug; 13(8):753-61. PubMed ID: 16543916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene-viral cancer therapy using dual-regulated oncolytic adenovirus with antiangiogenesis gene for increased efficacy.
    Su C; Na M; Chen J; Wang X; Liu Y; Wang W; Zhang Q; Li L; Long J; Liu X; Wu M; Fan X; Qian Q
    Mol Cancer Res; 2008 Apr; 6(4):568-75. PubMed ID: 18344493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant Sendai virus vector induces complete remission of established brain tumors through efficient interleukin-2 gene transfer in vaccinated rats.
    Iwadate Y; Inoue M; Saegusa T; Tokusumi Y; Kinoh H; Hasegawa M; Tagawa M; Yamaura A; Shimada H
    Clin Cancer Res; 2005 May; 11(10):3821-7. PubMed ID: 15897582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potent antitumor effect of TRAIL mediated by a novel adeno-associated viral vector targeting to telomerase activity for human hepatocellular carcinoma.
    Wang Y; Huang F; Cai H; Zhong S; Liu X; Tan WS
    J Gene Med; 2008 May; 10(5):518-26. PubMed ID: 18338833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenovirus-mediated delivery of human IFNgamma gene inhibits prostate cancer growth.
    Zhao P; Zhu YH; Wu JX; Liu RY; Zhu XY; Xiao X; Li HL; Huang BJ; Xie FJ; Chen JM; Ke ML; Huang W
    Life Sci; 2007 Aug; 81(9):695-701. PubMed ID: 17714738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitumor effects of systemically delivered adenovirus harboring trans-splicing ribozyme in intrahepatic colon cancer mouse model.
    Jeong JS; Lee SW; Hong SH; Lee YJ; Jung HI; Cho KS; Seo HH; Lee SJ; Park S; Song MS; Kim CM; Kim IH
    Clin Cancer Res; 2008 Jan; 14(1):281-90. PubMed ID: 18172280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenovirus-mediated gene transfer of pathogen-associated molecular patterns for cancer immunotherapy.
    Tosch C; Geist M; Ledoux C; Ziller-Remi C; Paul S; Erbs P; Corvaia N; Von Hoegen P; Balloul JM; Haegel H
    Cancer Gene Ther; 2009 Apr; 16(4):310-9. PubMed ID: 18949016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.